S-trityl-L-cysteine derivative induces caspase-independent cell death in K562 human chronic myeloid leukemia cell line

Cancer Letters

Volumn 298, Issue 1, 2010, Pages 99-106

  Shimizu, Makiko ^a   Ishii, Hirosuke ^a   Ogo, Naohisa ^a   Unno, Yuka ^a   Matsuno, Kenji ^a   Sawada, Jun ichi ^a   Akiyama, Yasuto ^b   Asai, Akira ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Apoptosis; Cell cycle; KSP; Leukemia; STLC

Indexed keywords

CASPASE 3; CYSTEINE DERIVATIVE; INITIATION FACTOR 4E BINDING PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; S TRITYL LEVO CYSTEINE DERIVATIVE; UNCLASSIFIED DRUG; 3-TRITYLTHIO-L-ALANINE; CASPASE; CYSTEINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG STRUCTURE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN SYNTHESIS INHIBITION; STRUCTURE ANALYSIS; ANALOGS AND DERIVATIVES; CELL CYCLE; CELL GROWTH; DRUG EFFECTS; ENZYMOLOGY; K562 CELL LINE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CASPASES; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYSTEINE; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;

EID: 77956918409     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.06.007     Document Type: Article

References (19)

1. Jackson J.R., Patrick D.R., Dar M.M., Huang P.S. Targeted anti-mitotic therapies: can we improve on tubulin agents?. Nat. Rev. Cancer 2007, 7:107-117.
2. Sarli V., Giannis A. Targeting the kinesin spindle protein: basic principles and clinical implications. Clin. Cancer Res. 2008, 14:7583-7587.
3. Orth J.D., Tang Y., Shi J., Loy C.T., Amendt C., Wilm C., Zenke F.T., Mitchison T.J. Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Mol. Cancer Ther. 2008, 7:3480-3489.
4. Mayer T.U., Kapoor T.M., Haggarty S.J., King R.W., Schreiber S.L., Mitchison T.J. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999, 286:971-974.
5. Amos L. Spindle assembly: kinesin-5 is in control. Curr. Biol. 2008, 23:R1146-11149.
6. Matsuno K., Sawada J., Asai A. Therapeutic potential of mitotic kinesin inhibitors in cancer. Expert Opin. Ther. Patents 2008, 18:253-274.
7. Zee-Cheng K.Y., Cheng C.C. Experimental antileukemic agents. Preparation and structure-activity study of S-tritylcysteine and related compounds. J. Med. Chem. 1970, 13:414-418.
8. Ogo N., Oishi S., Matsuno K., Sawada J., Fujii N., Asai A. Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors. Bioorg. Med. Chem. Lett. 2007, 17:3921-3924.
9. Debonis S., Skoufias D.A., Indorato R.L., Liger F., Marquet B., Laggner C., Joseph B., Kozielski F. Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5. J. Med. Chem. 2008, 13:1115-1125.
10. Kozielski F., Skoufias D.A., Indorato R.L., Saoudi Y., Jungblut P.R., Hustoft H.K., Strozynski M., Thiede B. Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5. Proteomics 2008, 8:289-300.
11. Proud C.G. The eukaryotic initiation factor 4E-binding proteins and apoptosis. Cell Death Differ. 2005, 12:541-546.
12. Tee A.R., Proud C.G. DNA-damaging agents cause inactivation of translational regulators linked to mTOR signaling. Oncogene 2000, 19:3021-3031.
13. Carter B.Z., Mak D.H., Shi Y., Schober W.D., Wang R.Y., Konopleva M., Koller E., Dean N.M., Andreeff M. Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: overcoming imatinib resistance. Cell Cycle 2006, 19:2223-2229.
14. Shimizu M., Ishii H., Ogo N., Matsuno K., Asai A. Biochemical analysis of cellular target of S-trityl-L-cysteine derivatives using affinity matrix. Bioorg. Med. Chem. Lett. 2010, 20:1578-1580.
15. Vijapurkar U., Wang W., Herbst R. Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways. Cancer Res. 2007, 67:237-245.
16. Bröker L.E., Kruyt F.A., Giaccone G. Cell death independent of caspases: a review. Clin. Cancer Res. 2005, 1:3155-3162.
17. Xiao D., Pinto J.T., Gundersen G.G., Weinstein I.B. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol. Cancer Ther. 2005, 4:1388-1398.
18. Tee A.R., Proud C.G. Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol. Cell. Biol. 2002, 22:1674-1683.
19. Liu M., Aneja R., Liu C., Sun L., Gao J., Wang H., Dong J.T., Sarli V., Giannis A., Joshi H.C., Zhou J. Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells. J. Biol. Chem. 2006, 281:18090-18097.